ACIP voted to recommend against anyone — adult, child and pregnant person — receiving a seasonal flu vaccine with the mercury ...

The letter, signed by 79 medical societies, expresses concern over recent federal immunization review policies and asks that ...

Cracking the genome's switchboard: How AI helps decode gene regulation by Aliyah Kovner, Lawrence Berkeley National Laboratory edited by Lisa Lock, reviewed by Robert Egan Editors' notes ...

Next up, there were some updates from the FDA about a new RSV vaccine for infants and a new treatment for gonorrhea. Andrea, tell us more about both of those. Garcia: So last week, the FDA approved a ...

Figure 1. In planta RNP-mediated genome editing in melon. (A) Microprojectile-mediated transfer of a GFP expression plasmid into melon SAMs. (B) Schematic outline of the iPB-RNP method for genome ...

Respiratory syncytial virus (RSV) is a leading cause of hospitalization in infants and young children, placing a significant burden on families, hospitals, and the healthcare system. Recent ...

This episode focused on the most pressing unmet needs in RSV prevention and the clinical impact of newly approved options. Tan highlighted a key issue from the initial rollout of nirsevimab: supply ...

The Food and Drug Administration (FDA) has expanded the approval of mResvia (respiratory syncytial virus [RSV] vaccine) to include active immunization in individuals 18 through 59 years of age who ...

Patients aged between 18 and 49 years more commonly had non-RSV vs RSV-related MAARI. Across all patients, those with RSV-related MAARI were more likely to have underlying coronary artery disease and ...

The ribosome is essential for protein synthesis and targeting its function serves as a platform for many therapies. Resistance gene-guided genome mining for a priori target identification has emerged ...

RSV exists as two subtypes, A and B, which are found within the genus Orthopneumovirus, family Pneumoviridae, order Mononegavirales. RSV is an enveloped, negative-sense, single-stranded (ss) RNA virus ...

(The Hill) — The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include individuals 18-59 years of age who are at increased risk for severe illness ...